164 related articles for article (PubMed ID: 1659595)
21. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG).
Watson FS; O'Connell JB; Amber IJ; Renlund DG; Classen D; Johnston JM; Smith CB; Bristow MR
J Heart Transplant; 1988; 7(2):102-5. PubMed ID: 2835468
[TBL] [Abstract][Full Text] [Related]
22. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
23. Combined prophylaxis decreases incidence of CMV-associated pneumonia after lung transplantation.
Solidoro P; Delsedime L; Bergallo M; Libertucci D; Ruffini E; Costa C; Rinaldi M; Amoroso A; Baldi S
Transplant Proc; 2009 May; 41(4):1347-8. PubMed ID: 19460556
[TBL] [Abstract][Full Text] [Related]
24. Treatment of cytomegalovirus infection.
Reed EC; Meyers JD
Clin Lab Med; 1987 Dec; 7(4):831-52. PubMed ID: 2446819
[TBL] [Abstract][Full Text] [Related]
25. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.
Preiksaitis JK; Sandhu J; Strautman M
Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284
[TBL] [Abstract][Full Text] [Related]
26. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.
Soghikian MV; Valentine VG; Berry GJ; Patel HR; Robbins RC; Theodore J
J Heart Lung Transplant; 1996 Sep; 15(9):881-7. PubMed ID: 8889983
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus infections in heart and heart and lung transplant recipients.
Wreghitt TG; Hakim M; Gray JJ; Kucia S; Wallwork J; English TA
J Clin Pathol; 1988 Jun; 41(6):660-7. PubMed ID: 2838530
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.
Mitsani D; Nguyen MH; Kwak EJ; Silveira FP; Vadnerkar A; Pilewski J; Crespo M; Toyoda Y; Bermudez C; Clancy CJ
J Heart Lung Transplant; 2010 Sep; 29(9):1014-20. PubMed ID: 20598582
[TBL] [Abstract][Full Text] [Related]
29. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Gluckman E; McMazeron ; Keable H; Meletis J; Bombail D; Jolivet I; Huart JJ; Nebout T; Cavazzana M; De Castro H
Nouv Rev Fr Hematol (1978); 1987; 29(1):17-21. PubMed ID: 3035485
[TBL] [Abstract][Full Text] [Related]
30. Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus-seronegative liver transplant recipients with cytomegalovirus-seropositive donors.
Winston DJ; Busuttil RW
Transplantation; 2004 Jan; 77(2):305-8. PubMed ID: 14742998
[TBL] [Abstract][Full Text] [Related]
31. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
32. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus infection and survival in lung transplant recipients.
Duncan AJ; Dummer JS; Paradis IL; Dauber JH; Yousem SA; Zenati MA; Kormos RL; Griffith BP
J Heart Lung Transplant; 1991; 10(5 Pt 1):638-44; discussion 645-6. PubMed ID: 1659899
[TBL] [Abstract][Full Text] [Related]
34. Early diagnosis and effective treatment of pulmonary CMV infection after lung transplantation.
Steinhoff G; Behrend M; Wagner TO; Höper MH; Haverich A
J Heart Lung Transplant; 1991; 10(1 Pt 1):9-14. PubMed ID: 1848789
[TBL] [Abstract][Full Text] [Related]
35. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
36. Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group.
Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG
Clin Infect Dis; 1996 Aug; 23(2):292-7. PubMed ID: 8842266
[TBL] [Abstract][Full Text] [Related]
37. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
[TBL] [Abstract][Full Text] [Related]
38. Three-year experience with human cytomegalovirus infections in heart transplant recipients.
Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G
J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498
[TBL] [Abstract][Full Text] [Related]
39. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome.
Tamm M; Aboyoun CL; Chhajed PN; Rainer S; Malouf MA; Glanville AR
Am J Respir Crit Care Med; 2004 Nov; 170(10):1120-3. PubMed ID: 15297275
[TBL] [Abstract][Full Text] [Related]
40. Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.
Potena L; Solidoro P; Patrucco F; Borgese L
Expert Opin Pharmacother; 2016 Aug; 17(12):1611-22. PubMed ID: 27340928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
